/
PDRX
$3.35+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.41 – $3.35
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$1.01
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.0M | $20.9M | $21.0M | $21.6M | $28.7M | $21.3M | $18.9M | $18.3M |
| Cost of revenue | $16.4M | $13.3M | $14.8M | $14.6M | $17.7M | $14.6M | $13.3M | $12.9M |
| Gross profit | $8.5M | $7.6M | $6.3M | $7.0M | $11.1M | $6.7M | $5.6M | $5.4M |
| Gross margin | 34.2% | 36.3% | 29.8% | 32.2% | 38.5% | 31.6% | 29.7% | 29.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $890.7K | −$65.7K | −$237.7K | $876.5K | $4.0M | −$190.5K | −$952.0K | −$477.4K |
| EBITDA | $1.2M | $162.9K | −$39.5K | $1.9M | $4.1M | $12.3K | −$560.0K | −$328.0K |
| Net income | $621.2K | −$12.9K | −$384.1K | $1.9M | $3.0M | −$98.1K | −$753.5K | −$257.5K |
| Net margin | 2.5% | -0.1% | -1.8% | 8.6% | 10.6% | -0.5% | -4.0% | -1.4% |
| EPS (diluted) | 0.36 | -0.01 | -0.22 | 1.08 | 1.83 | -0.06 | -0.46 | -0.17 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$3.99
Price
$3.35
Implied upside
+19%
Peer comparison
PD-RX PHARMACEUTICALS INC
PD-RX PHARMACEUTICALS INC
Held by traders on TradeandTell
No one on the platform currently holds PDRX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PDRX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PDRX yet.